[HTML][HTML] Advent of new perioperative care for fluid management after cardiovascular surgery: A review of current evidence

H Nishi - Journal of Cardiology, 2020 - Elsevier
Fluid management with diuretics is a key factor for postoperative management following
cardiovascular surgery, and it is common to administer intermittent doses of diuretics and …

First experience with Tolvaptan for the treatment of neonates and infants with capillary leak syndrome after cardiac surgery

A Kerling, O Toka, A Rüffer, H Müller, S Habash… - BMC pediatrics, 2019 - Springer
Background Postoperative fluid management in critically ill neonates and infants with
capillary leak syndrome (CLS) and extensive volume overload after cardiac surgery on …

Safety and effectiveness of tolvaptan for fluid management after pediatric cardiovascular surgery

Y Katayama, T Ozawa, N Shiono, H Masuhara… - General Thoracic and …, 2017 - Springer
Background Postoperative fluid management is important after open heart surgery, because
cardiopulmonary bypass evokes an abnormal inflammatory response and increases …

The role of tolvaptan administration after cardiac surgery: a meta-analysis

I Bellos, DC Iliopoulos, DN Perrea - Journal of Cardiothoracic and Vascular …, 2019 - Elsevier
Objective To evaluate the efficacy and safety of tolvaptan in fluid management after cardiac
surgery compared with conventional diuretic treatment. Design Systematic review of the …

Efficacy of tolvaptan for fluid management after cardiovascular surgery: A systematic review and meta‑analysis of randomized control trials

H Chen, W Jiang, X Li, Z Meng… - Experimental and …, 2020 - spandidos-publications.com
The purpose of this study was to systematically search the literature and analyze evidence
from randomized controlled trials (RCTs) comparing tolvaptan with conventional diuretics for …

Safety and effectiveness of tolvaptan administration after total arch replacement

Y Iida, A Yoshitake, H Shimizu - Annals of Vascular Surgery, 2019 - Elsevier
Background Postoperative fluid overload in cardiovascular surgery is associated with
increased mortality and morbidity. Recently, tolvaptan (TLV), a selective vasopressin V2 …

[PDF][PDF] Yuzo Katayama, Tsukasa Ozawa, Noritsugu Shiono, Hiroshi Masuhara

T Fujii, Y Watanabe - researchgate.net
Background Postoperative fluid management is important after open heart surgery, because
cardiopulmonary bypass evokes an abnormal inflammatory response and increases …

[引用][C] 选择性血管加压素V2 受体拮抗剂在心脏大血管外科围手术期的临床应用进展

王文君, 何学志, 高峰, 庄熙晶 - 临床荟萃, 2020

トルバプタンの弁膜症手術後胸水貯留抑制効果

青木淳, 尾本正, 丸田一人, 益田智章… - 日本心臓血管外科学会 …, 2019 - jstage.jst.go.jp
[目的] 心臓弁膜症術後管理におけるトルバプタンの有用性を検討した.[対象・方法] 対象は 2017 年
2 月から 2018 年に施行した心臓弁膜症手術症例中, 慢性透析症例, 再手術および緊急手術症例 …